AU Patent

AU2024291054A1 — Polymeric leuprolide acetate formulations

Assigned to Tolmar International Ltd · Expires 2025-11-27 · 0y expired

What this patent protects

Liquid-liquid polymer leuprolide acetate (LA) formulations comprising a biodegradable polymer and biocompatible solvent, and methods of using the formulations.

USPTO Abstract

Liquid-liquid polymer leuprolide acetate (LA) formulations comprising a biodegradable polymer and biocompatible solvent, and methods of using the formulations.

Drugs covered by this patent

leuprolide-mesylate (LEUPROLIDE MESYLATE)

Patent Metadata

Patent number: AU2024291054A1
Jurisdiction: AU
Classification: —
Expires: 2025-11-27
Drug substance claim: No
Drug product claim: No
Assignee: Tolmar International Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.